Structure of human drug transporters OATP1B1 and OATP1B3

被引:0
|
作者
Anca-Denise Ciută
Kamil Nosol
Julia Kowal
Somnath Mukherjee
Ana S. Ramírez
Bruno Stieger
Anthony A. Kossiakoff
Kaspar P. Locher
机构
[1] ETH Zürich,Institute of Molecular Biology and Biophysics, Department of Biology
[2] The University of Chicago,Department of Biochemistry and Molecular Biology
来源
Nature Communications | / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The organic anion transporting polypeptides OATP1B1 and OATP1B3 are membrane proteins that mediate uptake of drugs into the liver for subsequent conjugation and biliary excretion, a key step in drug elimination from the human body. Polymorphic variants of these transporters can cause reduced drug clearance and adverse drug effects such as statin-induced rhabdomyolysis, and co-administration of OATP substrates can lead to damaging drug-drug interaction. Despite their clinical relevance in drug disposition and pharmacokinetics, the structure and mechanism of OATPs are unknown. Here we present cryo-EM structures of human OATP1B1 and OATP1B3 bound to synthetic Fab fragments and in functionally distinct states. A single estrone-3-sulfate molecule is bound in a pocket located in the C-terminal half of OATP1B1. The shape and chemical nature of the pocket rationalize the preference for diverse organic anions and allow in silico docking of statins. The structure of OATP1B3 is determined in a drug-free state but reveals a bicarbonate molecule bound to the conserved signature motif and a histidine residue that is prevalent in OATPs exhibiting pH-dependent activity.
引用
收藏
相关论文
共 50 条
  • [1] Structure of human drug transporters OATP1B1 and OATP1B3
    Ciuta, Anca-Denise
    Nosol, Kamil
    Kowal, Julia
    Mukherjee, Somnath
    Ramirez, Ana S.
    Stieger, Bruno
    Kossiakoff, Anthony A.
    Locher, Kaspar P.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
    Chen, Yu
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (02) : 147 - 154
  • [3] Nuclear receptor ligands interact with the human liver transporters OATP1B1 and OATP1B3
    Hagenbuch, BH
    Obaidat, A
    Thompson, L
    FASEB JOURNAL, 2006, 20 (05): : A1143 - A1143
  • [4] Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3
    Bednarczyk, Dallas
    ANALYTICAL BIOCHEMISTRY, 2010, 405 (01) : 50 - 58
  • [5] Contribution of hepatic uptake transporters OATP1B1/OATP1B3 to the disposition of docetaxel
    Lee, Hye Jeong
    Leake, Brenda F.
    Teft, Wendy
    Kim, Richard B.
    Ho, Richard H.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Characteization of OATP1B1 and OATP1B3 inhibition by Nilotinib
    Sprowl, Jason A.
    Chen, Mingqing
    Gibson, Alice A.
    Pasquariello, Kyle Z.
    Sparreboom, Alex
    Hu, Shuiying
    FASEB JOURNAL, 2019, 33
  • [7] Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3
    Lu, Yanli
    Hu, Qingqing
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    XENOBIOTICA, 2019, 49 (02) : 239 - 246
  • [8] Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions
    Shitara, Yoshihisa
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (03) : 220 - 227
  • [9] Effect of clotrimazole on transport mediated by human OATP1B1 and OATP1B3
    Gui, Chunshan
    Thompson, Lucas
    Hagenbuch, Bruno
    HEPATOLOGY, 2006, 44 (04) : 379A - 379A
  • [10] Nostocyclopeptide-M1: A Potent, Nontoxic Inhibitor of the Hepatocyte Drug Transporters OATP1B3 and OATP1B1
    Herfindal, Lars
    Myhren, Lene
    Kleppe, Rune
    Krakstad, Camilla
    Selheim, Frode
    Jokela, Jouni
    Sivonen, Kaarina
    Doskeland, Stein O.
    MOLECULAR PHARMACEUTICS, 2011, 8 (02) : 360 - 367